Outset Medical, Inc. (NASDAQ:OM) SVP Marc Nash Sells 23,221 Shares

Outset Medical, Inc. (NASDAQ:OM) SVP Marc Nash sold 23,221 shares of the stock in a transaction that occurred on Tuesday, January 21st. The shares were sold at an average price of $0.80, for a total transaction of $18,576.80. Following the sale, the senior vice president now directly owns 204,968 shares of the company’s stock, valued at approximately $163,974.40. This trade represents a 10.18 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

Marc Nash also recently made the following trade(s):

• On Monday, January 13th, Marc Nash sold 15,011 shares of Outset Medical stock. The stock was sold at an average price of $0.81, for a total transaction of $12,158.91.
• On Tuesday, January 7th, Marc Nash sold 720 shares of Outset Medical stock. The shares were sold at an average price of $1.29, for a total transaction of $928.80.
• On Friday, November 15th, Marc Nash sold 1,375 shares of Outset Medical stock. The shares were sold at an average price of $0.80, for a total transaction of $1,100.00.

Outset Medical Price Performance

Outset Medical stock traded down $0.03 during mid-day trading on Wednesday, reaching $0.78. 951,459 shares of the company’s stock traded hands, compared to its average volume of 2,184,304. Outset Medical, Inc. has a 12-month low of $0.44 and a 12-month high of $5.22. The company has a quick ratio of 5.04, a current ratio of 6.49 and a debt-to-equity ratio of 4.12. The stock has a 50 day moving average of $1.01 and a two-hundred day moving average of $1.28. The company has a market cap of $40.98 million, a price-to-earnings ratio of -0.28 and a beta of 2.05.

Wall Street Analyst Weigh In

Separately, Royal Bank of Canada reiterated a “sector perform” rating and issued a $3.00 target price on shares of Outset Medical in a research report on Tuesday, January 7th.

Institutional Trading of Outset Medical

Several hedge funds have recently made changes to their positions in OM. National Bank of Canada FI grew its position in Outset Medical by 79.2% in the third quarter. National Bank of Canada FI now owns 52,407 shares of the company’s stock worth $35,000 after acquiring an additional 23,164 shares in the last quarter. Huntington National Bank lifted its stake in shares of Outset Medical by 46.2% in the 3rd quarter. Huntington National Bank now owns 63,306 shares of the company’s stock valued at $43,000 after purchasing an additional 20,000 shares during the last quarter. Vanguard Personalized Indexing Management LLC bought a new position in shares of Outset Medical during the 2nd quarter valued at approximately $49,000. Point72 Asia Singapore Pte. Ltd. purchased a new stake in Outset Medical during the 2nd quarter valued at $259,000. Finally, Squarepoint Ops LLC boosted its stake in Outset Medical by 74.1% during the second quarter. Squarepoint Ops LLC now owns 80,300 shares of the company’s stock worth $309,000 after buying an additional 34,187 shares during the period.

About Outset Medical

Outset Medical, Inc, a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables.